Table 3.
The antibiotic susceptible rate of Elizabethkingia species.*.
| Antimicrobial Agent | E. meningoseptica | E. miricola | E. anophelis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Han et al. [30] n = 17 |
Cheng et al. [31] n = 11 |
Lin et al. [19] n = 20 |
Han et al. [30] n = 18 |
Cheng et al. [31] n = 22 † |
Lau et al. [14] n = 17 |
Han et al. [30] n = 51 |
Perrin et al. [15] n = 25 |
Cheng et al. [31] n = 105 |
Chew et al. [38] n = 79 ‡ |
Lin et al. [19] n = 72 |
|
| South Korea | Taiwan | Taiwan | South Korea | Taiwan | Hong Kong | South Korea | USA | Taiwan | Singapore | Taiwan | |
| Piperacillin | 65 | - | 15 | 83 | - | 41·1 | 82 | 100 | - | - | 19·4 |
| Piperacillin-tazobactam | 100 | 73 | 5 | 94 | 73 | - | 92 | 92 | 73 | 92·4 | 30·6 |
| Ticarcillin-clavulanic acid | - | 0 | 0 | - | 0 | - | - | - | 0 | 21.5 | 0 |
| Cefoperazone-sulbactam | - | - | - | - | - | 100 | - | - | - | - | - |
| Ceftazidime | 0 | 0 | 0 | 0 | 0 | 5·9 | 0 | 0 | 0 | 0 | 0 |
| Cefepime | - | 0 | 0 | - | 9 | - | - | 92 | 4 | 0 | 2·8 |
| Ceftriaxone | - | - | 0 | - | - | - | - | - | - | - | 0 |
| Aztreonam | - | 0 | 0 | - | 0 | - | - | - | 0 | 1·3 | 0 |
| Ertapenem | - | 0 | 0 | - | 0 | - | - | - | 0 | - | 0 |
| Imipenem | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Meropenem | - | 0 | 0 | - | 0 | - | - | - | 0 | 0 | 0 |
| Doripenem | - | 0 | 0 | - | 0 | - | - | - | 0 | 0 | 0 |
| Gentamicin | 6 | 0 | 0 | 45 | 0 | 0 | 22 | 0 | 0 | 1·3 | 0 |
| Tobramycin | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Amikacin | - | 0 | 0 | - | 9 | 0 | - | 0 | 0 | 6·3 | 5·6 |
| Tetracycline | - | - | 0 | - | - | - | - | - | - | - | 0 |
| Minocycline | - | 100 | 60 | - | 100 | - | - | - | 98 | 97·5 | 100 |
| Doxycycline | - | 91 | - | - | 82 | - | - | - | 83 | 92·4 | - |
| Tigecycline | - | 55 | 15 | - | 50 | - | - | - | 20 | 5·1 | 26·4 |
| Ciprofloxacin | 23 | 0 | 10 | 56 | 14 | 100 | 22 | 92 | 1 | 21·5 | 9·7 |
| Levofloxacin | 35 | 55 | 30 | 100 | 77 | - | 29 | 96 | 16 | 78·5 | 58·3 |
| Moxifloxacin | 41 | - | - | 100 | - | - | 41 | - | - | - | - |
| Gatifloxacin | 35 | - | - | 100 | - | - | 33 | - | - | - | - |
| Trimethoprim-sulfamethoxazole | 6 | 0 | 10 | 28 | 18 | 70·6 | 22 | - | 4 | 92·4 | 12·5 |
| Rifampin | 94 | - | - | 66 | - | 58·8 | 96 | - | - | - | - |
| Vancomycin | 0 | - | 0 | 0 | - | 100 | 0 | - | - | - | 0 |
* Methods of minimum inhibitory concentration determination: Han et al. [30], agar dilution test; Cheng et al. [31], broth microdilution test; Lin et al. [19], broth microdilution test; Lau et al. [14], disk diffusion test; Perrin et al. [15], disk diffusion test; and Chew et al. [38], broth microdilution test. † Representing an “E. miricola cluster” that contains E. miricola, E. bruuniana, E. ursingii, and E. occulta. ‡ Containing one E. meningoseptica and 78 E. anophelis isolates.